Incyte Corporation
INCY
$99.13
-$1.19-1.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -15.54% | 10.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.54% | 10.31% | |||
| Cost of Revenue | -15.31% | 20.97% | |||
| Gross Profit | -15.76% | 1.83% | |||
| SG&A Expenses | -15.91% | 18.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.52% | 20.09% | |||
| Operating Income | -15.61% | -10.83% | |||
| Income Before Tax | -11.88% | -19.15% | |||
| Income Tax Expenses | -55.58% | 55.94% | |||
| Earnings from Continuing Operations | 1.35% | -29.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.35% | -29.44% | |||
| EBIT | -15.61% | -10.83% | |||
| EBITDA | -14.74% | -10.27% | |||
| EPS Basic | 0.38% | -30.08% | |||
| Normalized Basic EPS | -15.03% | -9.88% | |||
| EPS Diluted | 0.53% | -30.70% | |||
| Normalized Diluted EPS | -15.07% | -10.54% | |||
| Average Basic Shares Outstanding | 0.96% | 0.91% | |||
| Average Diluted Shares Outstanding | 1.01% | 1.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||